NFL

Ex-player, ALS patient Gleason pushes awareness

Team Gleason also tries to provide extraordinary experiences for ALS patients while at the same time raising awareness about ...
Yahoo Finance

QurAlis Doses First Patient With ALS in Phase 1 Clinical Trial Evaluating QRL-101, a First-in-Class Kv7 Precision Therapy for ALS

CAMBRIDGE, Mass., Dec. 4, 2024 /PRNewswire/ -- QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the ...

Tongue exercises for ALS patients show promise in preclinical study

Research at the University of Missouri could lead to new therapies for people with amyotrophic lateral sclerosis (ALS) and ...
PR Newswire

ALS.Community Launches Free, Patient-Led Online Community for ALS Support

ALS.Community today announced the public launch of its free, patient-led nonprofit online platform, giving people affected by ...

Neuralink brain data milestone: ALS patient calls implant a lifeline; Musk says it will help millions

Elon Musk acknowledged a Neuralink patient who shared about the impact of brain implants on his life. Jake Schneider, living ...
STAT

Autoimmune responses found in ALS, pointing to a new way to view the deadly disease

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Researchers have found that patients with amyotrophic lateral sclerosis have ...
STAT

After Amylyx ALS trial failure, patients share disappointment and fear — but some hope

The news last week that a Phase 3 trial of Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug — marketed as Relyvrio — failed to benefit patients compared to placebo hit the ALS patient ...
Medical Xpress

Experimental drug may benefit some patients with rare form of ALS

When Columbia neurologist and scientist Neil Shneider speaks to his ALS patients who volunteer for experimental therapies, he's unwaveringly honest. "Patients always ask me, 'What can I hope to get ...
Business Wire

Answer ALS Releases World's Largest ALS Patient-Based iPSC and Bio Data Repository

NEW ORLEANS--(BUSINESS WIRE)--In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) ...
Medical Xpress

ALS drug testing in patient-derived cells provides personalized window into nervous system

Unlike other pathologies, amyotrophic lateral sclerosis (ALS) cannot be reproduced accurately in animal models, complicating the development of effective drugs. Faced with this challenge, a group of ...

Outcomes of ALS patients admitted to the ICU for respiratory failure

A retrospective cohort study evaluating 3-month mortality and associated factors, as well as survival and functional ...
Fox News

Experimental ALS drug could offer new hope for patients if approved, researchers say

New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative ...